Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Advances in Brief

Loss of Heterozygosity in Sporadic Human Breast Carcinoma: A Common Region between 11q22 and 11q23.3

Garret M. Hampton, Arto Mannermaa, Robert Winquist, Martti Alavaikko, Guillermo Blanco, Pentti J. Taskinen, Heikki Kiviniemi, Irene Newsham, Webster K. Cavenee and Glen A. Evans
Garret M. Hampton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arto Mannermaa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Winquist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martti Alavaikko
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillermo Blanco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pentti J. Taskinen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heikki Kiviniemi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Newsham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Webster K. Cavenee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glen A. Evans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published September 1994
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The development of sporadic human breast cancer is associated with the accumulation of genetic alterations on several chromosomes. In the case of chromosome 11, loss of heterozygosity (LOH) at loci on the short arm has been well documented and suggests the presence of a suppressor gene(s) at 11p15.5. However, the evidence for similar events on the long arm is less compelling. Here, we determined the prevalence of LOH for chromosome 11q in 44 malignant and 3 benign cases of unselected sporadic breast tumor samples. We found that alteration of chromosome 11q is common in the pathogenesis of breast cancer as 19 of 44 (43%) malignant tumor specimens exhibited LOH. Eleven (58%) of these genetic alterations were specific to the long arm of the chromosome. The smallest region of shared LOH places the target between 11q22 and 11q23.3, the same general region frequently altered in cancers of the ovary, colon, skin, and uterine cervix, perhaps indicating the location of a tumor suppressor gene or genes of importance in each of these different tumor types.

Footnotes

  • ↵1 This study is supported in part by grants from the NIH (HG00202), the Department of Energy, the Harold G. and Leila Y. Mathers Foundation (G. A. E.), the Medical Research Council of the Academy of Finland (R. W.), the Ella and Georg Ehrnrooth Foundation (R. W.), and the University of Oulu (R. W., A. M., M. A., G. B., P. J. T., H. K.).

  • ↵2 Recipient of a long-term fellowship from the Human Frontier for Science Program.

  • ↵3 To whom requests for reprints should be addressed, at Ludwig Institute for Cancer Research, San Diego Branch, 9500 Gilman Drive, La Jolla, CA 92093-0660.

  • Received May 19, 1994.
  • Accepted July 15, 1994.
  • ©1994 American Association for Cancer Research.
PreviousNext
Back to top
September 1994
Volume 54, Issue 17
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Loss of Heterozygosity in Sporadic Human Breast Carcinoma: A Common Region between 11q22 and 11q23.3
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Loss of Heterozygosity in Sporadic Human Breast Carcinoma: A Common Region between 11q22 and 11q23.3
Garret M. Hampton, Arto Mannermaa, Robert Winquist, Martti Alavaikko, Guillermo Blanco, Pentti J. Taskinen, Heikki Kiviniemi, Irene Newsham, Webster K. Cavenee and Glen A. Evans
Cancer Res September 1 1994 (54) (17) 4586-4589;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Loss of Heterozygosity in Sporadic Human Breast Carcinoma: A Common Region between 11q22 and 11q23.3
Garret M. Hampton, Arto Mannermaa, Robert Winquist, Martti Alavaikko, Guillermo Blanco, Pentti J. Taskinen, Heikki Kiviniemi, Irene Newsham, Webster K. Cavenee and Glen A. Evans
Cancer Res September 1 1994 (54) (17) 4586-4589;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Advances in Brief

  • Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
  • Recombinant Listeria Vaccines Containing PEST Sequences Are Potent Immune Adjuvants for the Tumor-Associated Antigen Human Papillomavirus-16 E7
  • Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion cDNA for Cancer Gene Immunotherapy
Show more Advances in Brief

Articles

  • BCL-2 Gene Family and the Regulation of Programmed Cell Death
  • Role of TCL1 and ALL1 in Human Leukemias and Development
  • Introduction of H. Robert Horvitz
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement